Ole ensimmäinen seuraaja

RhoVac is a pharmaceutical company. Today, the focus is on the development of vaccines for the treatment of metastatic cancer. Immunotherapy treatment is a significant part of the business operations where the body's immune system is used to fight and eliminate cancer cells. The company's drug candidate is used in combination with surgery or radiation therapy. The company was established in 2007 and is based in Lund.